Jasmin Omar

Jasmin Omar

Auto-generated profile, based on publicly available information

Jasmin Omar

Institute of Pharmaceutical Science, King’s College London, 150 Stamford Street, SE1 9NH London, United Kingdom

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2021 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Open access
SLSuzette T. Lust
Suzette T. Lust
DJDominique de Jong-Hoogland
Dominique de Jong-Hoogland
MNMichael D. A. Norman
Michael D. A. Norman
CKCaoimhe Kerins
Caoimhe Kerins
JOJasmin Omar
Jasmin Omar
EGEileen Gentleman
Eileen Gentleman
Synthetic hydrogels formed from poly(ethylene glycol) (PEG) are widely used to study how cells interact with their extracellular matrix. These in vivo-like 3D environments provide a basis for tissue engineering and cell therapies but also for research into fundamental biological questions and disease modeling. The physical properties of PEG hydrogels can be modulated to provide mechanical cues to encapsulated cells; however, the impact of changing hydrogel stiffness on the diffusivity of solutes to and from encapsulated cells has received only limited attention. This is particularly true in selectively cross-linked “tetra-PEG” hydrogels, whose design limits network inhomogeneities. Here, we used a combination of theoretical calculations, predictive modeling, and experimental measurements of hydrogel swelling, rheological behavior, and diffusion kinetics to characterize tetra-PEG hydrogels’ permissiveness to the diffusion of molecules of biologically relevant size as we changed polymer concentration, and thus hydrogel mechanical strength. Our models predict that hydrogel mesh size has little effect on the diffusivity of model molecules and instead predicts that diffusion rates are more highly dependent on solute size. Indeed, our model predicts that changes in hydrogel mesh size only begin to have a non-negligible impact on the concentration of a solute that diffuses out of hydrogels for the smallest mesh sizes and largest diffusing solutes. Experimental measurements characterizing the diffusion of fluorescein isothiocyanate (FITC)-labeled dextran molecules of known size aligned well with modeling predictions and suggest that doubling the polymer concentration from 2.5% (w/v) to 5% produces stiffer gels with faster gelling kinetics without affecting the diffusivity of solutes of biologically relevant size but that 10% hydrogels can slow their diffusion. Our findings provide confidence that the stiffness of tetra-PEG hydrogels can be modulated over a physiological range without significantly impacting the transport rates of solutes to and from encapsulated cells.

1 April 2022 in Progress in Biomedical Engineering
Verified
Journal Article
Closed access
JOJasmin Omar
Jasmin Omar
CDCecile Dreiss
Cecile Dreiss
Xian Jun LohXian Jun Loh
Xian Jun Loh
Ocular diseases have serious implications on patients’ lives, with the majority causing blindness if left untreated. In 2020 it was estimated that 43 million people were blind worldwide which is expected to increase to 61 million by 2050. Due to the eye’s complex structure and defence mechanisms, there has been an ongoing challenge to deliver drugs which can penetrate the eyes’ barrier and reside at the site of action. Recent advances focus on the use of hydrogels, in particular temperature-responsive hydrogels, ‘thermogels’, to improve the properties of current therapies. Formulating a hydrogel-based system has shown to increase the bioavailability and biodegradability, provide a sustained release profile, enhance the drug permeation and residence time, as well as reduce the frequency of applications. This article provides a review of progress made over the past 5 years (2017–2021) using ‘thermogels’ for the treatment of some common or life-threatening ophthalmic conditions.